Benjamin Jackson Sells 4,727 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA) General Counsel Benjamin Jackson sold 4,727 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $7.32, for a total transaction of $34,601.64. Following the completion of the transaction, the general counsel now owns 135,528 shares in the company, valued at $992,064.96. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Sera Prognostics Trading Down 3.7 %

Shares of SERA stock opened at $6.97 on Thursday. Sera Prognostics, Inc. has a 12-month low of $1.65 and a 12-month high of $12.35. The stock’s 50-day moving average price is $7.40 and its 200-day moving average price is $7.65. The stock has a market capitalization of $232.59 million, a price-to-earnings ratio of -7.04 and a beta of 1.04.

Sera Prognostics (NASDAQ:SERA) last released its quarterly earnings data on Wednesday, November 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.02). The business had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.09 million. During the same period last year, the business posted ($0.23) earnings per share. As a group, research analysts predict that Sera Prognostics, Inc. will post -0.96 EPS for the current fiscal year.

Institutional Trading of Sera Prognostics

A number of institutional investors and hedge funds have recently made changes to their positions in the business. AWM Investment Company Inc. lifted its stake in shares of Sera Prognostics by 56.0% in the first quarter. AWM Investment Company Inc. now owns 584,664 shares of the company’s stock worth $5,320,000 after buying an additional 209,762 shares in the last quarter. RA Capital Management L.P. acquired a new position in shares of Sera Prognostics in the 1st quarter valued at $18,420,000. Sanders Morris Harris LLC boosted its stake in Sera Prognostics by 82.2% during the second quarter. Sanders Morris Harris LLC now owns 34,800 shares of the company’s stock worth $206,000 after buying an additional 15,700 shares during the period. Twelve Points Wealth Management LLC purchased a new stake in Sera Prognostics in the second quarter valued at approximately $257,000. Finally, Bank of New York Mellon Corp raised its holdings in shares of Sera Prognostics by 100.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock valued at $892,000 after buying an additional 75,441 shares during the period. 54.64% of the stock is currently owned by hedge funds and other institutional investors.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.